SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000077
Filing Date
2021-04-08
Accepted
2021-04-08 10:08:02
Documents
3
Period of Report
2021-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgbp040721form8l.htm 8-K 24974
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 54854
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 71473
  Complete submission text file 0001607062-21-000077.txt   152381
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 21814027
SIC: 2834 Pharmaceutical Preparations